{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T00:21:41Z","timestamp":1791418901575,"version":"4.3.3"},"reference-count":121,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2009,5,11]],"date-time":"2009-05-11T00:00:00Z","timestamp":1242000000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Int J Experimental Path"],"published-print":{"date-parts":[[2009,6]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p>The expansion of the synovial lining of joints in rheumatoid arthritis (RA) necessitates an increase in the vascular supply to the synovium, to cope with the increased requirement for oxygen and nutrients. New blood vessel formation \u2013\u2018angiogenesis\u2019\u2013 is recognized as a key event in the formation and maintenance of the pannus in RA, suggesting that targeting blood vessels in RA may be an effective future therapeutic strategy. Although many pro\u2010angiogenic factors have been demonstrated to be expressed in RA synovium, vascular endothelial growth factor (VEGF) has been demonstrated to a have a central involvement in the angiogenic process in RA. Nevertheless, it is unclear whether angiogenesis \u2013 whether driven by VEGF and\/or other factors \u2013 should be considered as a \u2018cause\u2019 or \u2018consequence\u2019 of disease. This ongoing \u2018chicken <jats:italic>vs.<\/jats:italic> egg\u2019 debate is difficult, as even the success of angiogenesis inhibition in models of RA does not provide a direct answer to the question. This review will focus on the role of the vasculature in RA, and the contribution of different angiogenic factors in promoting disease. Although no data regarding the effectiveness of anti\u2010angiogenic therapy in RA have been reported to date, the blockade of angiogenesis nevertheless looks to be a promising therapeutic avenue.<\/jats:p>","DOI":"10.1111\/j.1365-2613.2009.00640.x","type":"journal-article","created":{"date-parts":[[2010,9,23]],"date-time":"2010-09-23T14:47:52Z","timestamp":1285253272000},"page":"249-261","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":91,"title":["The vasculature in rheumatoid arthritis: cause or consequence?"],"prefix":"10.1111","volume":"90","author":[{"given":"Ewa M.","family":"Paleolog","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2009,5,11]]},"reference":[{"key":"e_1_2_4_2_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.gt.3302104"},{"key":"e_1_2_4_3_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2003.012617"},{"key":"e_1_2_4_4_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.RES.83.3.233"},{"key":"e_1_2_4_5_1","doi-asserted-by":"publisher","DOI":"10.1186\/ar2340"},{"key":"e_1_2_4_6_1","doi-asserted-by":"publisher","DOI":"10.1002\/1529-0131(200109)44:9<2055::AID-ART355>3.0.CO;2-2"},{"key":"e_1_2_4_7_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.171.9.4853"},{"key":"e_1_2_4_8_1","doi-asserted-by":"crossref","first-page":"3534","DOI":"10.1200\/jco.2006.24.18_suppl.3534","article-title":"Preliminary safety of bevacizumab with first\u2010line Folfox, Capox, Folfiri and capecitabine for mCRC\u2010\u2010First B.E.A.Trial","volume":"24","author":"Berry S.","year":"2006","journal-title":"J. Clin. Oncol."},{"key":"e_1_2_4_9_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.295.19.2275"},{"key":"e_1_2_4_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(89)90430-3"},{"key":"e_1_2_4_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(80)92831-7"},{"key":"e_1_2_4_12_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11920-008-0042-1"},{"key":"e_1_2_4_13_1","doi-asserted-by":"publisher","DOI":"10.1038\/380435a0"},{"key":"e_1_2_4_14_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/37.2.170"},{"key":"e_1_2_4_15_1","doi-asserted-by":"publisher","DOI":"10.1084\/jem.172.6.1535"},{"key":"e_1_2_4_16_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.271.30.17629"},{"key":"e_1_2_4_17_1","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.12-6-713"},{"key":"e_1_2_4_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0092-8674(03)00154-5"},{"key":"e_1_2_4_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0014-5793(97)01475-0"},{"key":"e_1_2_4_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0092-8674(00)81812-7"},{"key":"e_1_2_4_21_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.11213"},{"key":"e_1_2_4_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.yexcr.2004.04.013"},{"key":"e_1_2_4_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/0363-5023(88)90260-2"},{"key":"e_1_2_4_24_1","first-page":"799","article-title":"VEGF release is associated with reduced oxygen tensions in experimental inflammatory arthritis","volume":"20","author":"Etherington P.J.","year":"2002","journal-title":"Clin. Exp. Rheumatol."},{"key":"e_1_2_4_25_1","doi-asserted-by":"publisher","DOI":"10.1084\/jem.180.1.341"},{"key":"e_1_2_4_26_1","first-page":"260","article-title":"Angiopoietins, growth factors, and vascular morphology in early arthritis","volume":"30","author":"Fearon U.","year":"2003","journal-title":"J. Rheumatol."},{"key":"e_1_2_4_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1297-319X(01)00335-9"},{"key":"e_1_2_4_28_1","doi-asserted-by":"publisher","DOI":"10.1038\/380439a0"},{"key":"e_1_2_4_29_1","doi-asserted-by":"publisher","DOI":"10.1038\/nm0603-669"},{"key":"e_1_2_4_30_1","doi-asserted-by":"publisher","DOI":"10.1080\/030097401316909585"},{"key":"e_1_2_4_31_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard.50.11.792"},{"key":"e_1_2_4_32_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM197111182852108"},{"key":"e_1_2_4_33_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2004.031641"},{"key":"e_1_2_4_34_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.10705"},{"key":"e_1_2_4_35_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa050524"},{"key":"e_1_2_4_36_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.23940"},{"key":"e_1_2_4_37_1","doi-asserted-by":"publisher","DOI":"10.1186\/ar756"},{"key":"e_1_2_4_38_1","doi-asserted-by":"publisher","DOI":"10.1186\/ar1754"},{"key":"e_1_2_4_39_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard.62.2.100"},{"key":"e_1_2_4_40_1","doi-asserted-by":"publisher","DOI":"10.1002\/path.1778"},{"key":"e_1_2_4_41_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00011-003-1230-4"},{"key":"e_1_2_4_42_1","doi-asserted-by":"publisher","DOI":"10.1080\/03009749850154429"},{"key":"e_1_2_4_43_1","first-page":"3","article-title":"Excitement in synovium: the rapid evolution of understanding of rheumatoid arthritis and expectations for therapy","volume":"32","author":"Harris E.D.","year":"1992","journal-title":"J. Rheumatol. Suppl."},{"key":"e_1_2_4_44_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.10520"},{"key":"e_1_2_4_45_1","doi-asserted-by":"publisher","DOI":"10.1002\/1529-0131(200107)44:7<1540::AID-ART277>3.0.CO;2-7"},{"key":"e_1_2_4_46_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa032691"},{"key":"e_1_2_4_47_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.blo.0000205909.89845.f6"},{"key":"e_1_2_4_48_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard.56.11.686"},{"key":"e_1_2_4_49_1","doi-asserted-by":"publisher","DOI":"10.1186\/ar2447"},{"key":"e_1_2_4_50_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.00.232"},{"key":"e_1_2_4_51_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.bor.0000218951.65601.bf"},{"key":"e_1_2_4_52_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.23383"},{"key":"e_1_2_4_53_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa011110"},{"key":"e_1_2_4_54_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.1998.02563.x"},{"key":"e_1_2_4_55_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.10113"},{"key":"e_1_2_4_56_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0960-9822(98)70205-2"},{"key":"e_1_2_4_57_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.152.8.4149"},{"key":"e_1_2_4_58_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780390917"},{"key":"e_1_2_4_59_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pbio.0000083"},{"key":"e_1_2_4_60_1","doi-asserted-by":"publisher","DOI":"10.1128\/MCB.22.6.1704-1713.2002"},{"key":"e_1_2_4_61_1","first-page":"6737","article-title":"HGF\/NK4, a four\u2010kringle antagonist of hepatocyte growth factor, is an angiogenesis inhibitor that suppresses tumor growth and metastasis in mice","volume":"60","author":"Kuba K.","year":"2000","journal-title":"Cancer Res."},{"key":"e_1_2_4_62_1","first-page":"4339","article-title":"Weibel\u2010Palade bodies as a marker for neovascularization induced by tumor and rheumatoid angiogenesis factors","volume":"45","author":"Kumar P.","year":"1985","journal-title":"Cancer Res."},{"key":"e_1_2_4_63_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.22878"},{"key":"e_1_2_4_64_1","first-page":"321","article-title":"Vascular endothelial growth factor levels in the serum and synovial fluid of patients with rheumatoid arthritis","volume":"19","author":"Lee S.S.","year":"2001","journal-title":"Clin. Exp. Rheumatol."},{"key":"e_1_2_4_65_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.164.11.5922"},{"key":"e_1_2_4_66_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780130606"},{"key":"e_1_2_4_67_1","doi-asserted-by":"publisher","DOI":"10.1038\/nm731"},{"key":"e_1_2_4_68_1","first-page":"2102","article-title":"Modification of pro\u2010 and antiinflammatory cytokines and vascular\u2010related molecules by tumor necrosis factor\u2010a blockade in patients with rheumatoid arthritis","volume":"32","author":"Macias I.","year":"2005","journal-title":"J. Rheumatol."},{"key":"e_1_2_4_69_1","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.med.51.1.207"},{"key":"e_1_2_4_70_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(99)05246-0"},{"key":"e_1_2_4_71_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1535-6108(02)00044-2"},{"key":"e_1_2_4_72_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M702535200"},{"key":"e_1_2_4_73_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2005.05.131"},{"key":"e_1_2_4_74_1","doi-asserted-by":"publisher","DOI":"10.1038\/labinvest.3780127"},{"key":"e_1_2_4_75_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.11232"},{"key":"e_1_2_4_76_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.23935"},{"key":"e_1_2_4_77_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/39.11.1255"},{"key":"e_1_2_4_78_1","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s00125-002-0954-y","article-title":"HGF\/NK4 inhibited VEGF\u2010induced angiogenesis in in vitro cultured endothelial cells and in vivo rabbit model","volume":"46","author":"Nakabayashi M.","year":"2003","journal-title":"Diabetologia"},{"key":"e_1_2_4_79_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.11143"},{"key":"e_1_2_4_80_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard.53.1.45"},{"key":"e_1_2_4_81_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.20303"},{"key":"e_1_2_4_82_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.179.8.5504"},{"key":"e_1_2_4_83_1","doi-asserted-by":"publisher","DOI":"10.1038\/88842"},{"key":"e_1_2_4_84_1","doi-asserted-by":"publisher","DOI":"10.1002\/1529-0131(199807)41:7<1258::AID-ART17>3.0.CO;2-1"},{"key":"e_1_2_4_85_1","first-page":"213","article-title":"Direct actions of angiopoietin\u20101 on human endothelium: evidence for network stabilization, cell survival, and interaction with other angiogenic growth factors","volume":"79","author":"Papapetropoulos A.","year":"1999","journal-title":"Lab. Invest."},{"key":"e_1_2_4_86_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.11473"},{"key":"e_1_2_4_87_1","doi-asserted-by":"publisher","DOI":"10.1128\/MCB.25.13.5675-5686.2005"},{"key":"e_1_2_4_88_1","first-page":"7","article-title":"Production of platelet derived growth factor B chain (PDGF\u2010B\/c\u2010sis) mRNA and immunoreactive PDGF B\u2010like polypeptide by rheumatoid synovium: coexpression with heparin binding acidic fibroblast growth factor\u20101","volume":"18","author":"Remmers E.F.","year":"1991","journal-title":"J. Rheumatol."},{"key":"e_1_2_4_89_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780310803"},{"key":"e_1_2_4_90_1","doi-asserted-by":"publisher","DOI":"10.1016\/0049-0172(82)90020-8"},{"key":"e_1_2_4_91_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.febslet.2006.03.087"},{"key":"e_1_2_4_92_1","doi-asserted-by":"publisher","DOI":"10.1083\/jcb.200411105"},{"key":"e_1_2_4_93_1","doi-asserted-by":"publisher","DOI":"10.1083\/jcb.110.4.1417"},{"key":"e_1_2_4_94_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI116235"},{"key":"e_1_2_4_95_1","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djm086"},{"key":"e_1_2_4_96_1","first-page":"230","article-title":"Constitutive expression of angiopoietin\u20101 and \u20102 and modulation of their expression by inflammatory cytokines in rheumatoid arthritis synovial fibroblasts","volume":"29","author":"Scott B.B.","year":"2002","journal-title":"J. Rheumatol."},{"key":"e_1_2_4_97_1","first-page":"237","article-title":"Rheumatoid arthritis and osteoarthritis synovial fluid effects on primary human endothelial cell cultures","volume":"12","author":"Semble E.L.","year":"1985","journal-title":"J. Rheumatol."},{"key":"e_1_2_4_98_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0092-8674(01)00518-9"},{"key":"e_1_2_4_99_1","doi-asserted-by":"publisher","DOI":"10.1186\/ar407"},{"key":"e_1_2_4_100_1","doi-asserted-by":"publisher","DOI":"10.1080\/03009740410005845"},{"key":"e_1_2_4_101_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhsa.2007.09.002"},{"issue":"9","key":"e_1_2_4_102_1","first-page":"Abstract 357","article-title":"The Effect of Infliximab Therapy on the Prevention of New Erosions in Patients with Early Rheumatoid Arthritis","volume":"50","author":"Smolen J.","year":"2004","journal-title":"Arthritis Rheum."},{"key":"e_1_2_4_103_1","doi-asserted-by":"publisher","DOI":"10.1006\/bbrc.2001.4395"},{"key":"e_1_2_4_104_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0024-3205(01)01264-4"},{"key":"e_1_2_4_105_1","first-page":"6130","article-title":"Predominant role of hypoxia\u2010inducible transcription factor (Hif)\u20101alpha versus Hif\u20102alpha in regulation of the transcriptional response to hypoxia","volume":"63","author":"Sowter H.M.","year":"2003","journal-title":"Cancer Res."},{"key":"e_1_2_4_106_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780341206"},{"key":"e_1_2_4_107_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard.50.2.124"},{"key":"e_1_2_4_108_1","doi-asserted-by":"publisher","DOI":"10.1186\/ar608"},{"key":"e_1_2_4_109_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.21544"},{"key":"e_1_2_4_110_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780140407"},{"key":"e_1_2_4_111_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard.59.8.607"},{"key":"e_1_2_4_112_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.21932"},{"key":"e_1_2_4_113_1","first-page":"691","article-title":"Focally regulated endothelial proliferation and cell death in human synovium","volume":"152","author":"Walsh D.A.","year":"1998","journal-title":"Am. J. Pathol."},{"key":"e_1_2_4_114_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.92.12.5510"},{"key":"e_1_2_4_115_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.91.7.2762"},{"key":"e_1_2_4_116_1","first-page":"433","article-title":"Successful therapy of collagen\u2010induced arthritis with TNF receptor\u2010IgG fusion protein and combination with anti\u2010CD4","volume":"84","author":"Williams R.O.","year":"1995","journal-title":"Immunology"},{"key":"e_1_2_4_117_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.165.12.7240"},{"key":"e_1_2_4_118_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.coph.2007.06.001"},{"key":"e_1_2_4_119_1","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/S0749-0712(21)00066-4","article-title":"Extensor tendon ruptures in rheumatoid arthritis","volume":"11","author":"Williamson S.C.","year":"1995","journal-title":"Hand Clin."},{"key":"e_1_2_4_120_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.273.29.18514"},{"key":"e_1_2_4_121_1","doi-asserted-by":"publisher","DOI":"10.1096\/fj.07-8487com"},{"key":"e_1_2_4_122_1","first-page":"2184","article-title":"Levels of hepatocyte growth factor in synovial fluid and serum of patients with rheumatoid arthritis and release of hepatocyte growth factor by rheumatoid synovial fluid cells","volume":"21","author":"Yukioka K.","year":"1994","journal-title":"J. Rheumatol."}],"container-title":["International Journal of Experimental Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2613.2009.00640.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2613.2009.00640.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,14]],"date-time":"2023-10-14T21:56:09Z","timestamp":1697320569000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2613.2009.00640.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,5,11]]},"references-count":121,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2009,6]]}},"alternative-id":["10.1111\/j.1365-2613.2009.00640.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2613.2009.00640.x","archive":["Portico"],"relation":{},"ISSN":["0959-9673","1365-2613"],"issn-type":[{"value":"0959-9673","type":"print"},{"value":"1365-2613","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,5,11]]},"assertion":[{"value":"2009-05-11","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}